KROS Insider Trading Activity and SEC Form 4 Filings
KROS insider trading summary
Over the past 12 months, insiders at Keros Therapeutics, Inc. (KROS) reported 11 sales worth $495K by 8 insiders and 5 open-market purchases worth $53K by 1 insider on SEC Form 4. Net insider selling was $441K.
Latest KROS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Charles W. Newton | Insider | Sell | $6K (551 @ $10.30) |
| Aug 18, 2026 | Lorena Raquel Lerner | Chief Scientific Officer | Sell | $37K (3,568 @ $10.29) |
| Aug 18, 2026 | Annita Tanini | Corp. Controller & VP, Finance | Sell | $13K (1,224 @ $10.29) |
| Aug 18, 2026 | Esther Cho | Chief Legal Officer | Sell | $46K (4,485 @ $10.29) |
| Aug 17, 2026 | Jean Jacques Bienaime | Insider | Buy | $10K (1,000 @ $10.27) |
| Jul 15, 2026 | Jean Jacques Bienaime | Insider | Buy | $11K (1,000 @ $10.61) |
| Jun 15, 2026 | Jean Jacques Bienaime | Insider | Buy | $10K (1,000 @ $10.19) |
| Jun 11, 2026 | Charles W. Newton | Insider | Sell | $6K (550 @ $10.04) |
| Jun 4, 2026 | Julius Knowles | Insider | Sell | $28K (2,625 @ $10.73) |
| Jun 4, 2026 | Nima Farzan | Insider | Sell | $28K (2,625 @ $10.73) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.